Skip to main content

Advertisement

Log in

Carotid Intima-Media Thickness and Metabolic Complications in Children with HIV on Antiretroviral Therapy: A Cross-Sectional Study

  • Original Article
  • Published:
Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Objectives

To evaluate carotid intima media thickness (CIMT) in children with Human immunodeficiency virus (HIV) on anti-retroviral therapy (ART) and in controls. Also, to compare body mass index (BMI), body fat percentage, skin-fold thickness (SFT), waist-to-height ratio (WHtR), lipid profile, blood pressure, lipodystrophy syndrome (LDS), non-alcoholic fatty liver disease (NAFLD) in children with HIV and in controls and to determine association between lipid profile, LDS, liver amino-transferases, NAFLD, BMI, body fat percentage, SFT, WHtR and CIMT.

Methods

This cross-sectional study was done in 7 to 12 y old children attending the ART clinic and receiving ART for ≥6 mo according to 2018 National Aids Control Organization (NACO) guidelines. Thirty age and gender matched controls were enrolled from the pediatrics OPD. Weight, height, BMI, waist circumference, skin fold thickness and blood pressure were recorded. Lipid profile, liver amino-transferases, USG abdomen and CIMT were done with prior appointment.

Results

The present study had 43% females and 57% males (mean age of 9.33 ± 1.65 y). All cases were on combination ART (mean treatment duration: 59.1 mo). CIMT was significantly increased in cases as compared to controls 0.481 ± 0.087 mm vs. 0.418 ± 0.072 mm (p = 0.003). However, CIMT did not correlate with any other parameter. Cases had significantly higher body fat percentage (17% vs. 13.15%), systolic blood pressure (SBP), SFT, total cholesterol (TC) and low density lipoprotein- cholesterol (LDL-C) as compared to controls. NAFLD was seen in 3 cases (1%), lipohypertrophy in 7 (23%) cases and 5 (16%) controls.

Conclusions

Children with HIV on ART have significantly higher CIMT and increased metabolic abnormalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. National AIDS Control Organisation & ICMR-National Institute of Medical Statistics (2022). India HIV Estimates 2021: Technical Report. New Delhi: NACO, Ministry of Health & Family Welfare, Government of India. 2022. Available at: http://naco.gov.in/sites/default/files/India%20HIV%20Estimates.pdf. Accessed on 1 Aug 2022.

  2. Fortuny C, Deyà-Martínez Á, Chiappini E, Galli L, de Martino M, Noguera-Julian A. Metabolic and renal adverse effects of antiretroviral therapy in HIV-infected children and adolescents. Pediatr Infect Dis J. 2015;34:S36–43.

  3. Aurpibul L, Namwongprom S, Sudjaritruk T, Ounjaijean S. Metabolic syndrome, biochemical markers, and body composition in youth living with perinatal HIV infection on antiretroviral treatment. PLoS ONE. 2020;15:e0230707.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459–67.

    Article  PubMed  Google Scholar 

  5. Gupta PK, Gupta M, Lal AK, Taneja A, Taneja RS, Rewari BB. Markers of subclinical atherosclerotic disease in HIV-infected individuals. J Virus Erad. 2018;4:21–5.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Padmapriyadarsini C, Shet A, Srinivasan R, et al. High prevalence of lipid abnormalities and insulin resistance among antiretroviral naïve HIV-infected children in India. Pediatr Infect Dis J. 2018;37:253–7.

    Article  CAS  PubMed  Google Scholar 

  7. Mandal A, Mukherjee A, Lakshmy R, Kabra SK. Dyslipidemia in HIV infected children receiving highly active antiretroviral therapy. Indian J Pediatr. 2016;83:226–31.

    Article  PubMed  Google Scholar 

  8. Bhutia E, Hemal A, Yadav TP, Ramesh KL. Lipodystrophy syndrome among HIV infected children on highly active antiretroviral therapy in northern India. Afr Health Sci. 2014;14:408–13.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kumar P, Suri D, Vignesh P, Attri SV, Bhalla AK, Singh S. Metabolic abnormalities and clinical lipodystrophy in children with human immunodeficiency virus infection a report from a tertiary care center in India. Pediatr Infect Dis J. 2017;36:e313–6.

    Article  PubMed  Google Scholar 

  10. Parakh A, Dubey AP, Kumar A, Maheshwari A. Lipodystrophy and metabolic complications of highly active antiretroviral therapy. Indian J Pediatr. 2009;76:1017–21.

    Article  PubMed  Google Scholar 

  11. Chanthong P, Lapphra K, Saihongthong S, et al. Echocardiography and carotid intima-media thickness among asymptomatic HIV-infected adolescents in Thailand. AIDS. 2014;28:2071–9.

    Article  PubMed  Google Scholar 

  12. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;e5:13.

    Article  Google Scholar 

  13. Drole Torkar A, Plesnik E, Groselj U, Battelino T, Kotnik P. Carotid intima-media thickness in healthy children and adolescents: normative data and systematic literature review. Front Cardiovasc Med. 2020;7:597768.

    Article  PubMed  PubMed Central  Google Scholar 

  14. European Paediatric Lipodystrophy Group. Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe. AIDS. 2004;18:1443–51.

    Article  Google Scholar 

  15. Khadilkar A, Mandlik R, Chiplonkar S, Khadilkar V, Ekbote V, Patwardhan V. Reference centile curves for triceps skinfold thickness for Indian children aged 5–17 years and cut-offs for predicting risk of childhood hypertension: a multi-centric study. Indian Pediatr. 2015;52:675–80.

    Article  PubMed  Google Scholar 

  16. Sharma TS, Somarriba G, Arheart KL, et al. Longitudinal changes in body composition by dual-energy radiograph absorptiometry among perinatally HIV-infected and HIV-uninfected youth: increased risk of adiposity among HIV-infected female youth. Pediatr Infect Dis J. 2018;37:1002–7.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Arpadi S, Shiau S, Strehlau R, et al. Metabolic abnormalities and body composition of HIV-infected children on lopinavir or nevirapine-based antiretroviral therapy. Arch Dis Child. 2013;98:258–64.

    Article  PubMed  Google Scholar 

  18. Musiime V, Cook A, Kayiwa J, et al. Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial. Antivir Ther. 2014;19:269–76.

    Article  CAS  PubMed  Google Scholar 

  19. McComsey GA, Riordan MO, Hazen SL, et al. Increased carotid intima media thickness and cardiac biomarkers in HIV infected children. AIDS. 2007;21:921–7.

    Article  PubMed  Google Scholar 

  20. Bonnet D, Aggoun Y, Szezepanski I, Bellal N, Blanche S. Arterial stiffness and endothelial dysfunction in HIV-infected children. AIDS. 2004;18:1037–41.

    Article  PubMed  Google Scholar 

  21. Charakida M, Donald AE, Green H, et al. Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy. Circulation. 2005;112:103–9.

    Article  PubMed  Google Scholar 

  22. Mujawar Z, Rose H, Morrow MP, et al. Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol. 2006;4:e365.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Shah I. Adverse effects of antiretroviral therapy in HIV-1 infected children. J Trop Pediatr. 2006;52:244–8.

    Article  PubMed  Google Scholar 

  24. de Lima LRA, Petroski EL, Moreno YMF, et al. Dyslipidemia, chronic inflammation, and subclinical atherosclerosis in children and adolescents infected with HIV: the PositHIVe Health Study. PLoS ONE. 2018;13:e0190785.

    Article  Google Scholar 

  25. Marsico F, Lo Vecchio A, Paolillo S, et al. Left ventricular function, epicardial adipose tissue, and carotid intima-media thickness in children and adolescents with vertical HIV infection. J Acquir Immune Defic Syndr. 2019;82:462–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

KM: manuscript preparation, study sample collection and analysis of data; DH: study design and analysis and discussion of results; SG: analysis and discussion of results; VR: radiological evaluation of patients. DH will act as guarantor for this manuscript.

Corresponding author

Correspondence to Deepika Harit.

Ethics declarations

Conflict of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mukhuty, K., Harit, D., Gomber, S. et al. Carotid Intima-Media Thickness and Metabolic Complications in Children with HIV on Antiretroviral Therapy: A Cross-Sectional Study. Indian J Pediatr (2023). https://doi.org/10.1007/s12098-023-04950-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12098-023-04950-w

Keywords

Navigation